|
|
Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical cancer |
Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang( ) |
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
|
|
Abstract Cervical carcinoma is associated with high propensity for local invasion and lymph node metastasis. However, the molecular alterations that drive progression and metastasis of cervical cancer remain unclear. Cellular senescence has been proposed as the mechanism that protects an organism against cancer progression and metastasis. In addition, Twist, a basic helix-loop-helix transcription factor, has been suggested as an oncogene because it is overexpressed in many types of human cancer. This gene also exhibits a positive function in regulating invasion and metastasis. In this study, Twist was strongly and positively expressed in normal tissue, squamous cell carcinoma (SCC) IA--IIA, and SCC IIB--IIIB (4.3%, 44%, and 88.9%, respectively). The strong positive expressions of the senescence marker CBX3 were 39.1%, 32%, and 15.6%, respectively. The strong positive expressions of Twist in the SCC groups with or without lymph node metastasis were 80.8% and 50%. For CBX3, such expressions were 7.7% and 29.5%, respectively. Results also showed that the expression of Twist was inversely correlated with that of CBX3. Moreover, the knockdown of Twist with target siRNA in SiHa triggered the induction of the chromatin marker of the cellular senescence CBX3 and senescence-associated β-galactosidase activity. Our results suggested that the expression of Twist increased during the progression and metastasis of cervical cancer. Furthermore, Twist-induced senescence bypass is important in this process.
|
Keywords
cervical cancer
senescence
Twist
CBX3
lymph node metastasis
|
Corresponding Author(s):
Wang Shixuan,Email:sxwang2012@hotmail.com
|
Issue Date: 26 April 2014
|
|
1 |
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2(5): 342-350 doi: 10.1038/nrc798 pmid:12044010
|
2 |
Ozalp S, Yalcin OT, Oner U, Tanir HM, Acikalin M, Sarac I. Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions. Eur J Gynaecol Oncol 2003; 24(5): 425-428 pmid:14584662
|
3 |
Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192(4): 547-556 doi: 10.1083/jcb.201009094 pmid:21321098
|
4 |
Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, ?rntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444(7119): 633-637 doi: 10.1038/nature05268 pmid:17136093
|
5 |
Huang Y, Myers MP, Xu RM. Crystal structure of the HP1-EMSY complex reveals an unusual mode of HP1 binding. Structure 2006; 14(4): 703-712 doi: 10.1016/j.str.2006.01.007 pmid:16615912
|
6 |
Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012; 22(3): 194-207 doi: 10.1016/j.semcancer.2012.02.013 pmid:22406545
|
7 |
Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008; 20(2): 150-155 doi: 10.1016/j.ceb.2008.01.007 pmid:18353625
|
8 |
Smit MA, Peeper DS. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) 2010; 2(10): 735-741 pmid:20975209
|
9 |
Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 2012; 22(1): 90-106 doi: 10.1038/cr.2011.144 pmid:21876555
|
10 |
Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14(1): 79-89 doi: 10.1016/j.ccr.2008.06.005 pmid:18598946
|
11 |
Kwok WK, Ling MT, Yuen HF, Wong YC, Wang X. Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells. Carcinogenesis 2007; 28(12): 2467-2475 doi: 10.1093/carcin/bgm185 pmid:17690110
|
12 |
Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, Wang S. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 2012; 124(1): 112-118 doi: 10.1016/j.ygyno.2011.09.003 pmid:22018873
|
13 |
Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94(2): 153-156 doi: 10.1002/ijc.1440 pmid:11668491
|
14 |
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90 doi: 10.3322/caac.20107 pmid:21296855
|
16 |
Chandeck C, Mooi WJ. Oncogene-induced cellular senescence. Adv Anat Pathol 2010; 17(1): 42-48 pmid:20032638
|
17 |
Foroni C, Broggini M, Generali D, Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012; 38(6): 689-697 doi: 10.1016/j.ctrv.2011.11.001 pmid:22118888
|
18 |
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67(5): 1979-1987 doi: 10.1158/0008-5472.CAN-06-1479 pmid:17332325
|
19 |
Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12(18): 5369-5376 doi: 10.1158/1078-0432.CCR-05-2722 pmid:17000670
|
20 |
Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol 2012; 19(1): 326-335 doi: 10.1245/s10434-011-1867-0 pmid:21732143
|
21 |
Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement. Hum Pathol 2013; 44(2): 181-188 doi: 10.1016/j.humpath.2012.05.015 pmid:22974479
|
22 |
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139(5): 871-890 doi: 10.1016/j.cell.2009.11.007 pmid:19945376
|
23 |
Pedraza-Fari?a LG. Mechanisms of oncogenic cooperation in cancer initiation and metastasis. Yale J Biol Med 2006; 79(3-4): 95-103 pmid:17940619
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|